Online citations, reference lists, and bibliographies.
Please confirm you are human
(Sign Up for free to never see this)
← Back to Search

Insight Into Glycyrrhetinic Acid: The Role Of The Hydroxyl Group On Liver Targeting.

Qin Tian, X. Wang, W. Wang, Chuang-Nian Zhang, Yayuan Liu, Zhi Yuan
Published 2010 · Chemistry, Medicine

Save to my Library
Download PDF
Analyze on Scholarcy
Two kinds of glycyrrhetinic acid-modified chitosan/poly(ethylene glycol) nanoparticles (CTS/PEG-GA NPs) were prepared by an ionic gelation process in which the liver targeting ligand glycyrrhetinic acid (GA) was introduced into the nanoparticles at the C(30)-carboxyl group (CTS/PEG-GA(c) NPs) or the C(3)-hydroxyl group (CTS/PEG-GA(h) NPs). Their characteristics, especially their ability to target the liver, were compared. The results showed that both the CTS/PEG-GA(c) NPs and the CTS/PEG-GA(h) NPs are remarkably targeted to the liver. The accumulation in the liver is 51.3% and 56.5% of the injected dose for the CTS/PEG-GA(c)(4.60%) NPs (the subscript number denotes the GA content as weight percent in nanoparticles) and the CTS/PEG-GA(h)(4.57%) NPs at 3 h after injection, respectively. This is nearly 2.6-2.8 times higher than that obtained with the CTS/PEG NPs. According to our results, there is no significant difference between the CTS/PEG-GA(c) NPs and the CTS/PEG-GA(h) NPs in their ability to target the liver, when they were formed under identical conditions. This indicated that the C(3)-hydroxyl group in GA has little influence on the targeting ability.
This paper references
Self-assembled nanoparticles of hydrophobically-modified polysaccharide bearing vitamin H as a targeted anti-cancer drug delivery system.
K. Na (2003)
Effect of liposome composition and other factors on the targeting of liposomes to experimental tumors: biodistribution and imaging studies.
A. Gabizon (1990)
The synthesis of 18beta-glycyrrhetinic acid derivatives which have increased antiproliferative and apoptotic effects in leukemia cells.
Dan Liu (2007)
Antiviral effects of Glycyrrhiza species
C. Fiore (2008)
Glycyrrhetinic acid-modified poly(ethylene glycol)-b-poly(gamma-benzyl l-glutamate) micelles for liver targeting therapy.
W. Huang (2010)
Review of Pharmacological Effects of Glycyrrhiza sp. and its Bioactive Compounds
M. N. Asl (2008)
Preparation, characterization and uptake by primary cultured rat hepatocytes of liposomes surface-modified with glycyrrhetinic acid.
S. Mao (2007)
Synthesis of glycyrrhetinic acid derivatives for the treatment of metabolic diseases.
Igor Beseda (2010)
Hepatic stellate cell‐targeted delivery of M6P‐HSA‐glycyrrhetinic acid attenuates hepatic fibrogenesis in a bile duct ligation rat model
J. Luk (2007)
Novel hydrophilic chitosan‐polyethylene oxide nanoparticles as protein carriers
P. Calvo (1997)
Glycyrrhetinic acid-modified chitosan/poly(ethylene glycol) nanoparticles for liver-targeted delivery.
Q. Tian (2010)
pH‐sensitivity of hydrogels based on complex forming chitosan: Polyether interpenetrating polymer network
K. Yao (1993)
Specific binding of glycyrrhetinic acid to the rat liver membrane.
M. Negishi (1991)
Glycyrrhizin surface-modified chitosan nanoparticles for hepatocyte-targeted delivery.
Aihua Lin (2008)
Down-Regulation of a Hepatic Transporter Multidrug Resistance-Associated Protein 2 Is Involved in Alteration of Pharmacokinetics of Glycyrrhizin and Its Metabolites in a Rat Model of Chronic Liver Injury
T. Makino (2008)

This paper is referenced by
Synthesis, characterization and liver targeting evaluation of self‐assembled hyaluronic acid nanoparticles functionalized with glycyrrhetinic acid
Xiaodan Wang (2017)
Ligand-decorated polysaccharide nanocarriers for targeting therapeutics to hepatocytes
Sabyasachi Maiti (2017)
A conveniently synthesized Pt (IV) conjugated alginate nanoparticle with ligand self-shielded property for targeting treatment of hepatic carcinoma.
X. Wang (2019)
Glycyrrhetinic Acid Mediated Drug Delivery Carriers for Hepatocellular Carcinoma Therapy.
Yuee Cai (2016)
Controllable targeted system based on pH-dependent thermo-responsive nanoparticles.
Chengling Yang (2015)
Hepatocellular carcinoma-targeted effect of configurations and groups of glycyrrhetinic acid by evaluation of its derivative-modified liposomes
Y. Sun (2018)
Self-assembly and liver targeting of sulfated chitosan nanoparticles functionalized with glycyrrhetinic acid.
Q. Tian (2012)
Synthesis and anti-hepaticfibrosis of glycyrrhetinic acid derivatives with inhibiting COX-2.
Qiuping Zhang (2020)
Biodistribution and biocompatibility of glycyrrhetinic acid and galactose-modified chitosan nanoparticles as a novel targeting vehicle for hepatocellular carcinoma.
M. Li (2019)
Glycyrrhetinic acid-graft-hyaluronic acid conjugate as a carrier for synergistic targeted delivery of antitumor drugs.
L. Zhang (2013)
Recent advances in active hepatic targeting drug delivery system.
Y. Wang (2014)
Optimization on condition of glycyrrhetinic acid liposome by RSM and the research of its immunological activity.
X. Zhao (2012)
A wogonin-loaded glycyrrhetinic acid-modified liposome for hepatic targeting with anti-tumor effects
J. Tian (2014)
Studies on antineoplastic effect by adjusting ratios of targeted-ligand and antitumor drug
H. Guo (2014)
HPLC assay and pharmacokinetics and tissue distribution study of glycyrrhetinic acid liposomes modified with galactosylated lipid
Bo-hong Guo (2012)
Glycyrrhetinic acid protects mice from Staphylococcus aureus pneumonia.
Hong-en Li (2012)
Glycyrrhetinic acid-functionalized degradable micelles as liver-targeted drug carrier
W. Huang (2011)
Glycyrrhetinic Acid-Mediated Polymeric Drug Delivery Targeting the Acidic Microenvironment of Hepatocellular Carcinoma
J. Zhang (2015)
Design and synthesis of dual-ligand modified chitosan as a liver targeting vector
Houxiang Chen (2011)
Glycyrrhetinic Acid-Poly(ethylene glycol)-glycyrrhetinic Acid Tri-Block Conjugates Based Self-Assembled Micelles for Hepatic Targeted Delivery of Poorly Water Soluble Drug
Fengbo Wu (2013)
The anti-tumor performance of docetaxel liposomes surface-modified with glycyrrhetinic acid
J. Li (2012)
Paclitaxel and betulonic acid synergistically enhance antitumor efficacy by forming co-assembled nanoparticles.
J. Wang (2020)
Enhanced delivery of doxorubicin to the liver through self-assembled nanoparticles formed via conjugation of glycyrrhetinic acid to the hydroxyl group of hyaluronic acid.
Xiaodan Wang (2018)
Nanoconjugation and Encapsulation Strategies for Improving Drug Delivery and Therapeutic Efficacy of Poorly Water-Soluble Drugs
Thao Tran (2019)
Doxorubicin-loaded glycyrrhetinic acid modified recombinant human serum albumin nanoparticles for targeting liver tumor chemotherapy.
Wen-Wen Qi (2015)
Preparation of Glycyrrhetinic Acid Liposomes Using Lyophilization Monophase Solution Method: Preformulation, Optimization, and In Vitro Evaluation
Tingting Liu (2018)
Drug delivery system targeting advanced hepatocellular carcinoma: Current and future.
X. Zhang (2016)
Synthesis, biological evaluation and structure-activity relationships of glycyrrhetinic acid derivatives as novel anti-hepatitis B virus agents.
L. Wang (2012)
Nanomedicine As A Putative Approach For Active Targeting of Hepatocellular Carcinoma.
M. H. Elnaggar (2019)
Hepatic Targeting: Physiological Basis and Design Strategy
A. D’souza (2015)
Modified hyaluronic acid based materials for biomedical applications.
Sanjay Tiwari (2019)
Iron oxide nanoparticles for targeted imaging of liver tumors with ultralow hepatotoxicity.
J. Li (2018)
See more
Semantic Scholar Logo Some data provided by SemanticScholar